Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.48
+0.32 (3.20%)
Nov 3, 2026, 9:52 AM EST - Market open
Design Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $22 | Buy | Reiterates | $22 | +110.02% | Oct 13, 2026 |
| Wells Fargo No rating | Wells Fargo | Buy Initiates $26 | Buy | Initiates | $26 | +148.21% | Oct 12, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Buy Maintains $41 | Buy | Maintains | $41 | +287.02% | Aug 5, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $22 | Buy | Maintains | $22 | +110.02% | Aug 4, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 | Buy | Maintains | $20 | +90.93% | Aug 3, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $21 | Buy | Reiterates | $21 | +100.48% | Jun 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 | Buy | Maintains | $20 | +90.93% | May 27, 2026 |